Strong Quarterly Performance
Veeva Systems Inc. reported total revenue of $789 million for the second quarter, exceeding their guidance. Non-operating income was $353 million.
Resolution of IQVIA Lawsuit
The longstanding dispute with IQVIA has been resolved, removing historical barriers and potentially unlocking significant opportunities for collaboration and data integration.
AI Development and Future Potential
Veeva is making significant progress with Veeva AI, expected to transform the industry by increasing efficiency. Although not contributing materially in 2026 or 2027, it is expected to significantly increase Veeva's market size over time.
Broad-Based R&D Subscription Growth
R&D subscriptions and services saw substantial growth, driven by broad-based execution and a stable environment.
Positive Customer Reaction to IQVIA Collaboration
The resolution with IQVIA received overwhelmingly positive feedback from customers, indicating potential for improved collaboration and integration.
Top 20 Vault CRM Commitments
Veeva Systems Inc. secured commitments from nine top 20 pharmaceutical companies for Vault CRM, marking significant progress in customer adoption.
Crossix Growth
Continued strong performance in Crossix, driven by both measurement and audience business segments.